… boulardii CNCM I-745 as a complement to conventional triple therapy for Helicobacter
pylori infection decreased the frequency of gastrointestinal side effects that could be related to …

… Conclusion: Addition of S. boulardii CNCM I-745 to antibiotic treatment for H. pylori infection
induced a lower incidence of gastrointestinal symptoms possibly due to a lower abundance …

… The yeast Saccharomyces boulardii CNCM I-745 is one of the … sites of action of Saccharomyces
boulardii CNCM I-745: (1) An … from the complementary effect of several mechanisms. …

… yeast Saccharomyces boulardii CNCM I-745 has demonstrated its effectiveness as a probiotic
in the prevention and treatment of … protein and complement C4 decreased in reaction to S. …

… boulardii CNCM I-745 to the conventional antibiotic … or predicting the eradication effect of
Helicobacter pylori. In the future, … impact of Saccharomyces boulardii on Helicobacter pylori …

… Scientists have started to explore other alternative and complementary treatments to tackle
… to explore the effect of S. boulardii in combination with standard eradication therapy (triple …

… weeks after the therapy completion. Results: Saccharomyces boulardii and quadruple
therapy-combined intervention significantly reduced the incidences of overall side effects (27.8 vs. …

… yeast probiotic effects on the mycobiota on ATB treated mice, we evaluated the effect of
Saccharomyces boulardii CNCM I-745 administration on the mycobiota of mice treated for 10 …

… является штамм Saccharomyces boulardii CNCM I-745. … reduced the incidence of common
side effects (27.8 % versus 38.5 %, … boulardii CNCM I-745 as complementary treatment of He…

… boulardii CNCM I-745 hastened the return of the intestinal microbiota to its original … Effect
of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori …